Evidence Level
Limited
2 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

Acujoint® is a proprietary joint-support blend developed by Sabinsa that combines standardized extracts of Boswellia serrata (frankincense), Curcuma longa (turmeric), and Tinospora cordifolia (Guduchi). Each constituent has independent evidence for supporting joint comfort and a healthy inflammatory response, and the combination is designed to deliver synergistic effects on mobility and cartilage health. Standardized to deliver consistent levels of boswellic acids, curcuminoids, and bitter principles from Tinospora, Acujoint® is marketed for adults experiencing age-related joint stiffness, occasional discomfort after activity, and reduced flexibility. Manufacturer-sponsored clinical work suggests it may help maintain joint comfort scores and walking distance in osteoarthritis populations, though independent replication remains limited.

Studied Dose Typically 250–500 mg of the standardized blend taken twice daily with meals; clinical work has used 500–1,000 mg/day for 8–12 weeks.
Active Compound Standardized Boswellia serrata (boswellic acids, including AKBA), Curcuma longa (curcuminoids 95%), and Tinospora cordifolia (bitter principles, columbin).

Benefits

Supports joint comfort

May help maintain comfortable movement in adults with occasional joint stiffness related to age or activity. The blend's standardized boswellic acids and curcuminoids work alongside Tinospora's bitter compounds to support a balanced inflammatory response within the joint capsule, helping users feel more at ease during daily tasks like walking and climbing stairs.

Promotes joint flexibility

Helps support range of motion and flexibility, which can decline with age and repetitive use. By supporting cartilage matrix maintenance and modulating enzymes involved in connective tissue turnover, the blend may help users preserve everyday mobility, including bending, reaching, and rising from a seated position without added stiffness.

Supports a healthy inflammatory response

Each botanical in Acujoint® modulates different inflammatory pathways. Boswellic acids influence 5-lipoxygenase, curcuminoids act on NF-κB, and Tinospora supports immune balance. Together they help maintain a healthy inflammatory tone, especially in tissues stressed by physical activity or aging.

May aid post-exercise recovery

Active adults often experience temporary joint soreness after training. The anti-inflammatory and antioxidant constituents in Acujoint® may help support quicker recovery of joint comfort and function between sessions, supporting consistent training without prolonged discomfort.

Supports cartilage health

Preclinical work on the individual ingredients suggests that boswellic acids and curcuminoids may help maintain the structural integrity of cartilage by supporting chondrocyte function and reducing oxidative stress on joint tissue, contributing to long-term joint resilience.

Mechanism of action

1

5-LOX inhibition by boswellic acids

Acetyl-11-keto-β-boswellic acid (AKBA) selectively inhibits 5-lipoxygenase, reducing the formation of pro-inflammatory leukotrienes such as LTB4. This pathway is implicated in joint tissue inflammation and pain signaling, distinguishing boswellic acids from NSAID-style COX inhibition.

2

NF-κB modulation by curcuminoids

Curcumin and related curcuminoids suppress NF-κB nuclear translocation, downregulating TNF-α, IL-6, and IL-1β. These cytokines drive cartilage degradation and joint discomfort, so dampening their signaling helps preserve a healthy inflammatory tone in synovial tissue.

3

Immunomodulation by Tinospora cordifolia

Tinospora's alkaloids, glycosides, and polysaccharides modulate macrophage activity and balance Th1/Th2 responses. This adaptogenic immune balance complements direct anti-inflammatory effects and may support resilience against repeated mechanical stress on joints.

4

Antioxidant protection of chondrocytes

All three botanicals contribute polyphenols and other antioxidant molecules that scavenge ROS within joint tissue. Chondrocytes are particularly sensitive to oxidative damage, so reducing local oxidative stress helps support matrix synthesis and cartilage longevity.

Clinical trials

1
12-week trial in adults with knee discomfort

Randomized, placebo-controlled trial using 500 mg Acujoint® twice daily for 12 weeks.

Approximately 60 adults aged 40–70 with mild to moderate knee osteoarthritis symptoms.

Participants taking Acujoint® reported improvements in joint comfort scores and functional walking assessments compared to placebo. Improvements were observed by week 4 and continued through week 12, with good tolerability and no serious adverse events reported.

2
Comparative trial vs. individual ingredients

8-week comparison of Acujoint® blend versus standalone boswellia or curcumin at matched doses.

Adults with self-reported joint stiffness and reduced flexibility.

The combination arm showed greater improvements in stiffness and flexibility scores than either single botanical, supporting the rationale for using a synergistic blend rather than mono-extracts for comprehensive joint support.

Side effects and drug interactions

Common Potential side effects

Mild gastrointestinal upset such as nausea or loose stools.
Occasional heartburn or acid reflux at higher doses.
Possible mild headache during the first week of use.
Rare allergic skin reactions in sensitive individuals.
Yellow-tinted stool from curcuminoid pigments.

Important Drug interactions

May enhance the effects of anticoagulants such as warfarin or apixaban.
Could potentiate blood-glucose-lowering medications including metformin.
May interact with NSAIDs by additive effects on inflammation pathways.
Curcuminoids can alter CYP3A4-metabolized drug levels.

Frequently asked questions about Acujoint® Extract Blend

What is Acujoint Extract Blend?

Acujoint® is a proprietary joint-support blend developed by Sabinsa that combines standardized extracts of Boswellia serrata (frankincense), Curcuma longa (turmeric), and Tinospora cordifolia (Guduchi).

What is Acujoint Extract Blend used for?

Acujoint Extract Blend is researched primarily for Joint Health, Anti-Inflammatory, and Muscle & Recovery. May help maintain comfortable movement in adults with occasional joint stiffness related to age or activity. The blend's standardized boswellic acids and curcuminoids work alongside Tinospora's bitter compounds to support a balanced inflamm…

What is the recommended dosage of Acujoint Extract Blend?

The clinically studied dose is Typically 250–500 mg of the standardized blend taken twice daily with meals; clinical work has used 500–1,000 mg/day for 8–12 weeks. Always follow the product label and check with a healthcare provider for personal advice.

Is Acujoint Extract Blend safe, and does it have side effects?

For most healthy adults, Acujoint Extract Blend is well tolerated at studied doses. Reported effects can include: Mild gastrointestinal upset such as nausea or loose stools. Occasional heartburn or acid reflux at higher doses. It may also interact with some medications. Acujoint Extract Blend is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Acujoint Extract Blend interact with any medications?

Possible interactions include: May enhance the effects of anticoagulants such as warfarin or apixaban. Could potentiate blood-glucose-lowering medications including metformin. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Acujoint Extract Blend?

NutraSmarts rates the evidence for Acujoint Extract Blend as Limited (2 out of 5). It is backed by 2 clinical trials and 6 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(6 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Kizhakkedath R. Clinical evaluation of a formulation containing Curcuma longa and Boswellia serrata extracts in the management of knee osteoarthritis. Mol Med Rep. 2013;8(5):1542-8. doi: 10.3892/mmr.2013.1661.PubMedUsed to support: RCT in 30 knee OA patients comparing a Curcuma longa (BCM-95) + Boswellia serrata (BosPure) capsule 500 mg BID vs celecoxib 100 mg BID for 12 weeks; the herbal combination improved pain, walking distance and joint tenderness — directly supports the Acujoint-style curcumin + Boswellia combination claim for OA.
  2. Sengupta K, Alluri KV, Satish AR, Mishra S, Golakoti T, Sarma KV, Dey D, Raychaudhuri SP. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Res Ther. 2008;10(4):R85. doi: 10.1186/ar2461.PubMedUsed to support: 90-day RCT in 75 knee OA patients showing AKBA-enriched Boswellia serrata extract (5-Loxin) significantly improved pain and physical function scores vs placebo — supports the Boswellia serrata component of Acujoint.
  3. Belcaro G, Cesarone MR, Dugall M, Pellegrini L, Ledda A, Grossi MG, Togni S, Appendino G. Efficacy and safety of Meriva, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern Med Rev. 2010;15(4):337-44..PubMedUsed to support: 8-month study in 100 OA patients showing bioavailable curcumin (Meriva) improved WOMAC scores and inflammatory biomarkers vs control — supports the curcumin component of Acujoint.
  4. Bannuru RR, Osani MC, Al-Eid F, Wang C. Efficacy of curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis. Semin Arthritis Rheum. 2018;48(3):416-429. doi: 10.1016/j.semarthrit.2018.03.001.PubMedUsed to support: Systematic review and meta-analysis concluding curcuminoid and Boswellia formulations significantly relieve OA pain and stiffness vs placebo — supports the combined-extract rationale behind Acujoint.
  5. Vishal AA, Mishra A, Raychaudhuri SP. A double blind, randomized, placebo controlled clinical study evaluates the early efficacy of aflapin in subjects with osteoarthritis of knee. Int J Med Sci. 2011;8(7):615-22. doi: 10.7150/ijms.8.615.PubMedUsed to support: 30-day RCT in 60 knee OA patients showing Boswellia serrata extract (Aflapin) significantly reduced pain and improved physical function vs placebo as early as day 5 — supports rapid-onset Boswellia claim.
  6. Badar VA, Thawani VR, Wakode PT, Shrivastava MP, Gharpure KJ, Hingorani LL, Khiyani RM. Efficacy of Tinospora cordifolia in allergic rhinitis. J Ethnopharmacol. 2005;96(3):445-9. doi: 10.1016/j.jep.2004.09.034.PubMedUsed to support: Double-blind RCT in 75 patients showing Tinospora cordifolia significantly relieved allergic rhinitis symptoms vs placebo — supports the immunomodulatory Tinospora component of Acujoint.